A detailed history of Martingale Asset Management L P transactions in Merck & Co., Inc. stock. As of the latest transaction made, Martingale Asset Management L P holds 352,047 shares of MRK stock, worth $34.6 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares
352,047
Previous 417,300 15.64%
Holding current value
$34.6 Million
Previous $51.7 Million 22.61%
% of portfolio
0.94%
Previous 1.13%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $7.25 Million - $8.42 Million
-65,253 Reduced 15.64%
352,047 $40 Million
Q2 2024

Aug 12, 2024

SELL
$123.8 - $132.96 $5.07 Million - $5.45 Million
-40,956 Reduced 8.94%
417,300 $51.7 Million
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $5.17 Million - $6.02 Million
-45,621 Reduced 9.05%
458,256 $60.5 Million
Q4 2023

Feb 12, 2024

SELL
$100.18 - $109.02 $2.02 Million - $2.2 Million
-20,160 Reduced 3.85%
503,877 $54.9 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $2.32 Million - $2.58 Million
-22,559 Reduced 4.13%
524,037 $53.9 Million
Q2 2023

Aug 11, 2023

SELL
$108.61 - $118.38 $4.9 Million - $5.34 Million
-45,147 Reduced 7.63%
546,596 $63.1 Million
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $4.56 Million - $5.09 Million
-44,321 Reduced 6.97%
591,743 $63 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $7.96 Million - $10.2 Million
-91,058 Reduced 12.52%
636,064 $70.6 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $2.12 Million - $2.39 Million
-25,127 Reduced 3.34%
727,122 $62.6 Million
Q2 2022

Aug 11, 2022

SELL
$83.49 - $94.64 $7.67 Million - $8.69 Million
-91,861 Reduced 10.88%
752,249 $68.6 Million
Q1 2022

May 12, 2022

SELL
$73.51 - $82.4 $6.52 Million - $7.3 Million
-88,629 Reduced 9.5%
844,110 $69.3 Million
Q4 2021

Feb 11, 2022

SELL
$72.28 - $90.54 $4.26 Million - $5.34 Million
-58,955 Reduced 5.94%
932,739 $71.5 Million
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $8.67 Million - $9.53 Million
-120,888 Reduced 10.87%
991,694 $74.5 Million
Q2 2021

Aug 13, 2021

SELL
$70.31 - $77.77 $4.41 Million - $4.88 Million
-62,754 Reduced 5.34%
1,112,582 $86.5 Million
Q1 2021

May 13, 2021

SELL
$68.86 - $81.11 $1.43 Million - $1.69 Million
-20,804 Reduced 1.74%
1,175,336 $86.5 Million
Q4 2020

Feb 10, 2021

BUY
$71.77 - $79.65 $4.8 Million - $5.32 Million
66,833 Added 5.92%
1,196,140 $93.4 Million
Q3 2020

Nov 12, 2020

BUY
$73.18 - $82.95 $1.31 Million - $1.48 Million
17,899 Added 1.61%
1,129,307 $89.4 Million
Q2 2020

Aug 10, 2020

BUY
$70.42 - $80.13 $1.05 Million - $1.2 Million
14,936 Added 1.36%
1,111,408 $82 Million
Q1 2020

May 11, 2020

SELL
$63.36 - $87.82 $985,121 - $1.37 Million
-15,548 Reduced 1.4%
1,096,472 $80.5 Million
Q4 2019

Feb 10, 2020

BUY
$77.58 - $87.54 $4.45 Million - $5.02 Million
57,384 Added 5.44%
1,112,020 $96.5 Million
Q3 2019

Nov 13, 2019

BUY
$76.08 - $82.93 $16.1 Million - $17.6 Million
212,087 Added 25.17%
1,054,636 $84.7 Million
Q2 2019

Aug 13, 2019

BUY
$69.84 - $81.59 $6.92 Million - $8.08 Million
99,065 Added 13.32%
842,549 $0
Q1 2019

May 08, 2019

BUY
$69.58 - $79.36 $3.68 Million - $4.2 Million
52,866 Added 7.65%
743,484 $0
Q4 2018

Feb 11, 2019

SELL
$65.24 - $75.71 $265,004 - $307,534
-4,062 Reduced 0.58%
690,618 $50.4 Million
Q3 2018

Nov 09, 2018

BUY
$57.69 - $67.84 $295,430 - $347,408
5,121 Added 0.74%
694,680 $0
Q2 2018

Aug 09, 2018

BUY
$50.83 - $59.72 $792,948 - $931,632
15,600 Added 2.31%
689,559 $0
Q1 2018

May 11, 2018

SELL
$50.96 - $59.23 $2.8 Million - $3.26 Million
-55,003 Reduced 7.55%
673,959 $0
Q4 2017

Feb 12, 2018

SELL
$51.62 - $61.64 $8.75 Million - $10.5 Million
-169,554 Reduced 18.87%
728,962 $0
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $52.7 Million - $56.7 Million
898,516
898,516 $57.5 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.